Cargando…
Injection site reaction induced by liraglutide use in a female patient with obesity
INTRODUCTION: Glucagon-like peptide-1 agonists (GLP-1 agonists) are one of the top treatment options in obesity and/or type 2 diabetes (T2D) according to the guidelines. It is well tolerated in patients with cardiovascular disease or chronic kidney disease. Allergic symptoms such as rash and pruritu...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653154/ http://dx.doi.org/10.1210/jcemcr/luac014.039 |